Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure

James D. Lewis, Brian Strom, Stephen E. Kimmel, John Farrar, David C. Metz, Colleen Brensinger, Lisa Nessel, A. Russell Localio

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: Because of the difficulty in establishing a gold standard, data on accuracy of recall of over-the-counter (OTC) medication use are sparse. Methods: We studied a cohort of 1889 persons living in the Philadelphia area to assess recall of non-aspirin non-steroidal anti-inflammatory drug (NANSAID) use during the preceding 8 weeks. Our analyses were based on the assumption that among the group of subjects, on average, the reported usage of NANSAIDs should not vary over the previous 8 weeks. To model the effect of time on reported usage while allowing for the inherent correlation of responses within subjects over time, we employed alternating logistic regression. Results: We documented a significant decline in reported use of OTC NANSAIDs but not prescription NANSAIDs during the 8-week study period (p=0.3 for frequent prescription NANSAIDs, p=0.2 for infrequent prescription NANSAIDs, p < 0.001 for frequent OTC NANSAIDs, and p < 0.001 for infrequent OTC NANSAIDs). Reported rates of frequent and infrequent OTC NANSAID consumption declined from 6.3 to 4.6% and from 17.1 to 12.8% between the most recent week and eight weeks prior, respectively. Conclusions: Interviews focusing on medications used on an as needed basis should be performed as close as possible to the index date. Likewise, data on frequent use of OTC NANSAIDs may be more reliable than that on infrequent use, particularly when subjects are asked to recall more than a few weeks back in time.

Original languageEnglish (US)
Pages (from-to)39-45
Number of pages7
JournalPharmacoepidemiology and drug safety
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Prescriptions
Anti-Inflammatory Agents
Pharmaceutical Preparations
Logistic Models
Interviews

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Epidemiology

Cite this

Lewis, James D. ; Strom, Brian ; Kimmel, Stephen E. ; Farrar, John ; Metz, David C. ; Brensinger, Colleen ; Nessel, Lisa ; Localio, A. Russell. / Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. In: Pharmacoepidemiology and drug safety. 2006 ; Vol. 15, No. 1. pp. 39-45.
@article{219e4ca5c2304dbcb8af2ea8903ec2a1,
title = "Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure",
abstract = "Purpose: Because of the difficulty in establishing a gold standard, data on accuracy of recall of over-the-counter (OTC) medication use are sparse. Methods: We studied a cohort of 1889 persons living in the Philadelphia area to assess recall of non-aspirin non-steroidal anti-inflammatory drug (NANSAID) use during the preceding 8 weeks. Our analyses were based on the assumption that among the group of subjects, on average, the reported usage of NANSAIDs should not vary over the previous 8 weeks. To model the effect of time on reported usage while allowing for the inherent correlation of responses within subjects over time, we employed alternating logistic regression. Results: We documented a significant decline in reported use of OTC NANSAIDs but not prescription NANSAIDs during the 8-week study period (p=0.3 for frequent prescription NANSAIDs, p=0.2 for infrequent prescription NANSAIDs, p < 0.001 for frequent OTC NANSAIDs, and p < 0.001 for infrequent OTC NANSAIDs). Reported rates of frequent and infrequent OTC NANSAID consumption declined from 6.3 to 4.6{\%} and from 17.1 to 12.8{\%} between the most recent week and eight weeks prior, respectively. Conclusions: Interviews focusing on medications used on an as needed basis should be performed as close as possible to the index date. Likewise, data on frequent use of OTC NANSAIDs may be more reliable than that on infrequent use, particularly when subjects are asked to recall more than a few weeks back in time.",
author = "Lewis, {James D.} and Brian Strom and Kimmel, {Stephen E.} and John Farrar and Metz, {David C.} and Colleen Brensinger and Lisa Nessel and Localio, {A. Russell}",
year = "2006",
month = "1",
day = "1",
doi = "https://doi.org/10.1002/pds.1134",
language = "English (US)",
volume = "15",
pages = "39--45",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

Lewis, JD, Strom, B, Kimmel, SE, Farrar, J, Metz, DC, Brensinger, C, Nessel, L & Localio, AR 2006, 'Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure', Pharmacoepidemiology and drug safety, vol. 15, no. 1, pp. 39-45. https://doi.org/10.1002/pds.1134

Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. / Lewis, James D.; Strom, Brian; Kimmel, Stephen E.; Farrar, John; Metz, David C.; Brensinger, Colleen; Nessel, Lisa; Localio, A. Russell.

In: Pharmacoepidemiology and drug safety, Vol. 15, No. 1, 01.01.2006, p. 39-45.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure

AU - Lewis, James D.

AU - Strom, Brian

AU - Kimmel, Stephen E.

AU - Farrar, John

AU - Metz, David C.

AU - Brensinger, Colleen

AU - Nessel, Lisa

AU - Localio, A. Russell

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Purpose: Because of the difficulty in establishing a gold standard, data on accuracy of recall of over-the-counter (OTC) medication use are sparse. Methods: We studied a cohort of 1889 persons living in the Philadelphia area to assess recall of non-aspirin non-steroidal anti-inflammatory drug (NANSAID) use during the preceding 8 weeks. Our analyses were based on the assumption that among the group of subjects, on average, the reported usage of NANSAIDs should not vary over the previous 8 weeks. To model the effect of time on reported usage while allowing for the inherent correlation of responses within subjects over time, we employed alternating logistic regression. Results: We documented a significant decline in reported use of OTC NANSAIDs but not prescription NANSAIDs during the 8-week study period (p=0.3 for frequent prescription NANSAIDs, p=0.2 for infrequent prescription NANSAIDs, p < 0.001 for frequent OTC NANSAIDs, and p < 0.001 for infrequent OTC NANSAIDs). Reported rates of frequent and infrequent OTC NANSAID consumption declined from 6.3 to 4.6% and from 17.1 to 12.8% between the most recent week and eight weeks prior, respectively. Conclusions: Interviews focusing on medications used on an as needed basis should be performed as close as possible to the index date. Likewise, data on frequent use of OTC NANSAIDs may be more reliable than that on infrequent use, particularly when subjects are asked to recall more than a few weeks back in time.

AB - Purpose: Because of the difficulty in establishing a gold standard, data on accuracy of recall of over-the-counter (OTC) medication use are sparse. Methods: We studied a cohort of 1889 persons living in the Philadelphia area to assess recall of non-aspirin non-steroidal anti-inflammatory drug (NANSAID) use during the preceding 8 weeks. Our analyses were based on the assumption that among the group of subjects, on average, the reported usage of NANSAIDs should not vary over the previous 8 weeks. To model the effect of time on reported usage while allowing for the inherent correlation of responses within subjects over time, we employed alternating logistic regression. Results: We documented a significant decline in reported use of OTC NANSAIDs but not prescription NANSAIDs during the 8-week study period (p=0.3 for frequent prescription NANSAIDs, p=0.2 for infrequent prescription NANSAIDs, p < 0.001 for frequent OTC NANSAIDs, and p < 0.001 for infrequent OTC NANSAIDs). Reported rates of frequent and infrequent OTC NANSAID consumption declined from 6.3 to 4.6% and from 17.1 to 12.8% between the most recent week and eight weeks prior, respectively. Conclusions: Interviews focusing on medications used on an as needed basis should be performed as close as possible to the index date. Likewise, data on frequent use of OTC NANSAIDs may be more reliable than that on infrequent use, particularly when subjects are asked to recall more than a few weeks back in time.

UR - http://www.scopus.com/inward/record.url?scp=31744435114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31744435114&partnerID=8YFLogxK

U2 - https://doi.org/10.1002/pds.1134

DO - https://doi.org/10.1002/pds.1134

M3 - Article

VL - 15

SP - 39

EP - 45

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 1

ER -